Here are four observations:
1. A rising geriatric population, an increasing demand for hip and knee replacements and a growing awareness of orthopedic disorders drive the orthopedic biomaterial market.
2. Governments are also awarding grants for biomaterial research.
3. Metals currently dominate the market, but ceramics, polymers and orthobiologics are expected to see double digit growth within the next five years.
4. The growing failure of joint implants and the rising costs of biomaterials pose obstacles to the market’s growth.
More articles on orthopedics:
Dr. Michael Graham to present MIS technique at international conference: 3 points
North Cornwall Health Center, Orthopedic Associates of Lancaster, to open: 4 notes
Dr. Alexandra Page becomes USBJI Chronic Osteoarthritis Management Initiative co-chair: 5 key notes
